Bronchoalveolar T lymphocytes and pulmonary sarcoidosis
- PMID: 3886118
- DOI: 10.1007/BF02992985
Bronchoalveolar T lymphocytes and pulmonary sarcoidosis
Abstract
In recent years, our understanding of the pathogenesis of sarcoidosis has markedly changed. Originally, it was felt that sarcoidosis was a disease that was caused by a state of anergy. More recent studies suggest that sarcoidosis is not a disease of anergy but is mediated by a classic, heightened cellular immune process. It is hoped that additional studies utilizing inflammatory and immune effector cells obtained from sites of disease will further elucidate the pathogenic mechanisms leading to granuloma formation in patients with sarcoidosis.
Similar articles
-
Role of alveolar macrophage- and lung T cell-derived mediators in pulmonary sarcoidosis.Ann N Y Acad Sci. 1986;465:82-90. doi: 10.1111/j.1749-6632.1986.tb18483.x. Ann N Y Acad Sci. 1986. PMID: 2425678 Review.
-
NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.Ann Intern Med. 1981 Jan;94(1):73-94. doi: 10.7326/0003-4819-94-1-73. Ann Intern Med. 1981. PMID: 7004303 Review.
-
[Bronchoalveolar immunoglobulins in sarcoidosis].Schweiz Med Wochenschr. 1985 Jan 19;115(3):103-5. Schweiz Med Wochenschr. 1985. PMID: 3871964 German.
-
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.J Clin Invest. 1985 May;75(5):1488-95. doi: 10.1172/JCI111852. J Clin Invest. 1985. PMID: 3923038 Free PMC article.
-
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.N Engl J Med. 1980 Mar 13;302(11):594-8. doi: 10.1056/NEJM198003133021102. N Engl J Med. 1980. PMID: 6965420
References
Publication types
MeSH terms
LinkOut - more resources
Medical